Request Trial
5 January 2026NewsCareersMarisa Woutersen

Bird & Bird targets Nordic life sciences growth with regulatory hire

The firm brings in a former Plesner director and Novo Nordisk in-house counsel with regulatory and compliance expertise.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Mintz gains ex-Winston & Strawn partner and ITC expert
20 February 2026   The new hire has “deep experience in high-stakes International Trade Commission proceedings”, whose specialisms include medical devices, pharma and genomics.
Careers
Hogan Lovells makes senior public and administrative hire in Italy
18 February 2026   A lawyer with three decades of experience across energy, technology, life sciences, sports and media has joined the firm's Global Regulatory & IP practice in Milan.
Careers
Norton Rose Fulbright expands pharma and biotech disputes team
13 February 2026   The firm recruits two Cooley partners with expertise in Hatch-Waxman, BPCIA, trade secrets, and competitor versus competitor patent litigation.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

BioNTech fires shots at Moderna's next-generation vaccine
Mintz gains ex-Winston & Strawn partner and ITC expert
Abbott unit defends European protection for heart valve ‘cuff’ design
Natera targets ex-employee over mass file download before rival move
Hogan Lovells makes senior public and administrative hire in Italy
Danaher moves to acquire Masimo in $9.9bn deal
Generic rival blocked as AZ defends diabetes stronghold
Emotional Perception exclusive: ‘We are now very much open for business’